Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

NCT01356901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2015-07-07

No results posted yet for this study

Summary

The purpose of this observational study is to measure the real-life persistence, adherence and clinical effectiveness of entecavir in patients with chronic Hepatitis B viral infection.

Conditions

  • Hepatitis B, Chronic

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01356901 on ClinicalTrials.gov